Raymond James & Associates’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-860
| Closed | -$6.22K | – | 3811 |
|
|
2023
Q3 | $6.22K | Hold |
860
| – | – | ﹤0.01% | 3734 |
|
|
2023
Q2 | $4.54K | Sell |
860
-3,333
| -79% | -$17.6K | ﹤0.01% | 3764 |
|
|
2023
Q1 | $13K | Sell |
4,193
-143
| -3% | -$444 | ﹤0.01% | 3770 |
|
|
2022
Q4 | $17.2K | Sell |
4,336
-1,813
| -29% | -$7.17K | ﹤0.01% | 3730 |
|
|
2022
Q3 | $23K | Buy |
6,149
+1,816
| +42% | +$6.79K | ﹤0.01% | 3721 |
|
|
2022
Q2 | $58K | Hold |
4,333
| – | – | ﹤0.01% | 3716 |
|
|
2022
Q1 | $21K | Sell |
4,333
-40
| -0.9% | -$194 | ﹤0.01% | 3883 |
|
|
2021
Q4 | $30K | Sell |
4,373
-12,901
| -75% | -$88.5K | ﹤0.01% | 3905 |
|
|
2021
Q3 | $532K | Sell |
17,274
-743
| -4% | -$22.9K | ﹤0.01% | 3008 |
|
|
2021
Q2 | $585K | Buy |
18,017
+990
| +6% | +$32.1K | ﹤0.01% | 2967 |
|
|
2021
Q1 | $644K | Sell |
17,027
-5,495
| -24% | -$208K | ﹤0.01% | 2808 |
|
|
2020
Q4 | $1.07M | Buy |
22,522
+12,762
| +131% | +$604K | ﹤0.01% | 2294 |
|
|
2020
Q3 | $315K | Buy |
9,760
+1,866
| +24% | +$60.2K | ﹤0.01% | 2908 |
|
|
2020
Q2 | $348K | Buy |
+7,894
| New | +$348K | ﹤0.01% | 2819 |
|
|
2018
Q1 | – | Sell |
-5,719
| Closed | -$585K | – | 3383 |
|
|
2017
Q4 | $585K | Buy |
+5,719
| New | +$585K | ﹤0.01% | 2426 |
|